1. Home
  2. PRSO vs PTIX Comparison

PRSO vs PTIX Comparison

Compare PRSO & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRSO
  • PTIX
  • Stock Information
  • Founded
  • PRSO 2008
  • PTIX 1994
  • Country
  • PRSO United States
  • PTIX United States
  • Employees
  • PRSO N/A
  • PTIX N/A
  • Industry
  • PRSO Semiconductors
  • PTIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PRSO Technology
  • PTIX Health Care
  • Exchange
  • PRSO Nasdaq
  • PTIX Nasdaq
  • Market Cap
  • PRSO 7.4M
  • PTIX 6.3M
  • IPO Year
  • PRSO 2001
  • PTIX 2016
  • Fundamental
  • Price
  • PRSO $1.37
  • PTIX $3.42
  • Analyst Decision
  • PRSO Strong Buy
  • PTIX
  • Analyst Count
  • PRSO 1
  • PTIX 0
  • Target Price
  • PRSO $3.00
  • PTIX N/A
  • AVG Volume (30 Days)
  • PRSO 621.0K
  • PTIX 104.7K
  • Earning Date
  • PRSO 11-11-2025
  • PTIX 11-13-2025
  • Dividend Yield
  • PRSO N/A
  • PTIX N/A
  • EPS Growth
  • PRSO N/A
  • PTIX N/A
  • EPS
  • PRSO N/A
  • PTIX N/A
  • Revenue
  • PRSO $13,608,000.00
  • PTIX N/A
  • Revenue This Year
  • PRSO N/A
  • PTIX N/A
  • Revenue Next Year
  • PRSO $47.61
  • PTIX N/A
  • P/E Ratio
  • PRSO N/A
  • PTIX N/A
  • Revenue Growth
  • PRSO 1.80
  • PTIX N/A
  • 52 Week Low
  • PRSO $0.52
  • PTIX $2.25
  • 52 Week High
  • PRSO $2.34
  • PTIX $15.26
  • Technical
  • Relative Strength Index (RSI)
  • PRSO 61.34
  • PTIX 44.43
  • Support Level
  • PRSO $1.18
  • PTIX $3.22
  • Resistance Level
  • PRSO $1.35
  • PTIX $3.53
  • Average True Range (ATR)
  • PRSO 0.07
  • PTIX 0.28
  • MACD
  • PRSO 0.00
  • PTIX -0.09
  • Stochastic Oscillator
  • PRSO 88.87
  • PTIX 8.27

About PRSO Peraso Inc.

Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

Share on Social Networks: